An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions

Pharmacokinetics

Interventions

DRUG

AZD6140

90mg tablet, oral, once daily for the first day and twice daily from day 4 to 9

DRUG

AZD6140

90 x 2 mg tablets, oral, once daily for the first day and twice daily from day 4 to 9

Trial Locations (1)

Research Site, Beijing